Follow
Brenda  Gibbens-Bandala
Title
Cited by
Cited by
Year
Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis
RM Trujillo-Nolasco, E Morales-Avila, BE Ocampo-Garcia, G Ferro-Flores, ...
Materials Science and Engineering: C 103, 109766, 2019
772019
177Lu-Bombesin-PLGA (paclitaxel): A targeted controlled-release nanomedicine for bimodal therapy of breast cancer
B Gibbens-Bandala, E Morales-Avila, G Ferro-Flores, C Santos-Cuevas, ...
Materials Science and Engineering: C 105, 110043, 2019
542019
Biodegradable poly (D, L-lactide-co-glycolide)/poly (L-γ-glutamic acid) nanoparticles conjugated to folic acid for targeted delivery of doxorubicin
L Jaimes-Aguirre, E Morales-Avila, BE Ocampo-García, LA Medina, ...
Materials Science and Engineering: C 76, 743-751, 2017
482017
Polymer-based drug delivery systems, development and pre-clinical status
L Jaimes-Aguirre, BV Gibbens-Bandala, E Morales-Avila, ...
Current Pharmaceutical Design 22 (19), 2886-2903, 2016
452016
Synthesis and Evaluation of 177Lu-DOTA-DN (PTX)-BN for Selective and Concomitant Radio and Drug—Therapeutic Effect on Breast Cancer Cells
B Gibbens-Bandala, E Morales-Avila, G Ferro-Flores, C Santos-Cuevas, ...
Polymers 11 (10), 1572, 2019
312019
Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer
P Cruz-Nova, A Ancira-Cortez, G Ferro-Flores, B Ocampo-García, ...
Pharmaceutics 14 (5), 1095, 2022
142022
Multimeric system of RGD-grafted PMMA-nanoparticles as a targeted drug-delivery system for paclitaxel
GB Brenda Vianey, OG Blanca Eli, FF Guillermina, MA Enrique, ...
Current Pharmaceutical Design 23 (23), 3415-3422, 2017
122017
Development of 177Lu-DN (C19)-CXCR4 Ligand Nanosystem for Combinatorial Therapy in Pancreatic Cancer
M Trujillo-Nolasco, P Cruz-Nova, G Ferro-Flores, B Gibbens-Bandala, ...
Journal of Biomedical Nanotechnology 17 (2), 263-278, 2021
102021
Toxicity Assessment of [177Lu] Lu− iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes
T Hernández-Jiménez, P Cruz-Nova, A Ancira-Cortez, ...
Nanomaterials 12 (23), 4181, 2022
92022
[99mTc]Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients
L Coria-Domínguez, P Vallejo-Armenta, M Luna-Gutiérrez, ...
Pharmaceuticals 15 (5), 590, 2022
32022
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC …
M Luna-Gutiérrez, R Hernández-Ramírez, A Soto-Abundiz, ...
Pharmaceutics 15 (7), 1988, 2023
22023
Dendrimers as Targeted Systems for Selective Gene and Drug Delivery
B Gibbens-Bandala, M Trujillo-Nolasco, P Cruz-Nova, L Aranda-Lara, ...
Pharmaceutical Nanobiotechnology for Targeted Therapy, 361-397, 2022
22022
Dual-targeted therapy and molecular imaging with radiolabeled nanoparticles
B Ocampo-García, B Gibbens-Bandala, E Morales-Avila, ...
Biotechnology Products in Everyday Life, 201-219, 2019
22019
Chemo-radiotherapy with 177Lu-PLGA (RGF)-CXCR4L for the targeted treatment of colorectal cancer
P Cruz-Nova, B Gibbens-Bandala, A Ancira-Cortez, G Ramírez-Nava, ...
Frontiers in Medicine 10, 1191315, 2023
12023
Pharmaceutical nanoplatforms based on self-nanoemulsifying drug delivery systems for optimal transport and co-delivery of siRNAs and anticancer drugs
L Reyna-Lázaro, A Morales-Becerril, L Aranda-Lara, K Isaac-Olivé, ...
Journal of Pharmaceutical Sciences, 2024
2024
Cancer nanoimmunotherapy in the present scenario
A Ancira-Cortez, B Gibbens-Bandala, P Cruz-Nova, L Meléndez-Alafort, ...
Functionalized Nanomaterials for Cancer Research, 653-681, 2024
2024
[Tc-99m] Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients
L Coria-Dominguez, P Vallejo-Armenta, M Luna-Gutierrez, ...
PHARMACEUTICALS 15 (5), 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–17